022 82 44 44

Possibilities

High accuracy (>99%) in detecting lung cancer
Identification of patients (triage) who are indicated subsequent diagnostic procedures (invasive biopsy, etc.)

Who is the test recommended for?

Patients recommended for an invasive biopsy due to suspected lung cancer based on clinical-laboratory and/or imaging data (MRI)
Patients for whom an invasive biopsy is not possible, or whose recent lung biopsy was inconclusive or did not correspond to clinical observations
Patients previously diagnosed and treated for lung cancer, and who are currently suspected of having a recurrence

Diagnostic Characteristics

The clinical sensitivity of the test is 99.83%, as confirmed on samples from 1,256 patients with lung cancer.
The clinical specificity of the test is 98.70% and 95.47%, as established in the evaluation of 700 cases with benign disease and 12,009 asymptomatic individuals, respectively.
The clinical sensitivity and specificity of the test for detecting circulating tumor DNA are 73.17% and 93.75%, respectively.

Decided to take the test!

Book your first consultation with a doctor

The doctor will inform you about the upcoming testing, answer any questions you may have, and then ask you to sign an informed consent form for the test. Then, the doctor will complete a special form (application) according to the requirements of Trublood

Book a consultation

Where can I get tested?

Chisinau

21 N. Теstemițanu, street
Monday – Tuesday, 07:30 - 14:30 I Wednesday, 07:30 - 09:00

Laboratory Report

The test results provided in the laboratory report are intended for professional use only by qualified specialists, considering the capabilities/limitations/characteristics of the test, the patient's current health status, clinical history, and diagnostic data, and, if necessary, should be confirmed/excluded by standard medical procedures.

VIEW SAMPLE REPORTS IN ENGLISH

Not detected

Detected